海寧皮城(002344.SZ)2020年度財務預算報告:營收12.5億元、歸屬於上市公司股東淨利潤2億元
格隆匯4月10日丨海寧皮城(002344.SZ)公佈,公司第五屆董事會第二次會議召開,審議通過《關於審議2020年度財務預算報告的議案》。2020年公司計劃全年實現營業收入12.5億元,營業利潤3億元,計劃實現歸屬於上市公司股東的淨利潤2億元。
特別提示:本預算為公司2020年度經營計劃的內部管理控制指標,不代表公司盈利預測,能否實現取決於宏觀經濟環境、市場情況、行業發展狀況與公司管理團隊的努力等多種因素,存在很大的不確定性,請投資者注意投資風險。
該議案尚需提交公司2019年年度股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.